Sclerostin Modulation Holds Promise for Dental Indications

Sclerostin Modulation Holds Promise for Dental Indications

Sclerostin modulation is a novel therapeutic bone regulation strategy. The anti-sclerostin drugs, proposed in medicine for skeletal bone loss may be developed for jaw bone indications in dentistry. Alveolar bone responsible for housing dentition share common bone remodeling mechanisms with skeletal...

Full description

Bibliographic Details
Main Authors:	Mohamed G. Hassan, Abbas R. Zaher, Juan Martin Palomo, Leena Palomo
Format:	Article
Language:	English
Published:	MDPI AG 2018-11-01
Series:	Healthcare
Subjects:	sclerostin anti-sclerostin bone remodeling alveolar bone orthodontic tooth movement periodontitis bone loss
Online Access:	https://www.mdpi.com/2227-9032/6/4/134

Similar Items

Expression of sclerostin in alveolar bone remodeling of ovariectomized rats
by: GUO Ying, et al.
Published: (2020-12-01)

Expression of SOST/sclerostin in compressed periodontal ligament cells
by: Masae Ueda, et al.
Published: (2016-09-01)

Serum Sclerostin Level Among Egyptian Rheumatoid Arthritis Patients: Relation to Disease Activity ,Bone Mineral Density and Radiological Grading
by: Dina Ahmed Mehaney, et al.
Published: (2015-07-01)

Clinical Inference of Serum and Bone Sclerostin Levels in Patients with End-Stage Kidney Disease
by: Annelies De Maré, et al.
Published: (2019-11-01)

Anti-Sclerostin Antibodies in Osteoporosis and Other Bone Diseases
by: Stéphanie Fabre, et al.
Published: (2020-10-01)

Simvastatin attenuates tibial bone loss in rats with type 1 diabetes and periodontitis
by: Ae Ri Kim, et al.
Published: (2018-11-01)

Identification of Sclerostin as a Putative New Myokine Involved in the Muscle-to-Bone Crosstalk
by: Maria Sara Magarò, et al.
Published: (2021-01-01)

Effect of recombinant mouse sclerostin proteins on bone formation in vitro and in a murine model of sclerosteosis
by: Dreyer, Timothy James
Published: (2021)

Sclerostin and Osteocalcin: Candidate Bone-Produced Hormones
by: Jialiang S. Wang, et al.
Published: (2021-03-01)

Regulation of sclerostin in glucocorticoid-induced osteoporosis (GIO) in mice and humans
by: Sylvia Thiele, et al.
Published: (2019-07-01)

Sclerostin Blood Levels Before and After Kidney Transplantation
by: Marco Bonani, et al.
Published: (2014-07-01)

Recombinant sclerostin inhibits bone formation in vitro and in a mouse model of sclerosteosis
by: Timothy Dreyer, et al.
Published: (2021-07-01)

Serum sclerostin in rheumatoid-induced osteoporosis
by: Ola Gharbia, et al.
Published: (2020-07-01)

Circulating sclerostin is associated with bone mineral density independent of HIV-serostatus
by: Ryan D. Ross, et al.
Published: (2020-06-01)

Role of Osteocytes in Myeloma Bone Disease: Anti-sclerostin Antibody as New Therapeutic Strategy
by: Denise Toscani, et al.
Published: (2018-10-01)

Serum sclerostin concentration reflects bone turnover and glycation in men with type 2 diabetes mellitus
by: Eisuke Tomatsu, et al.
Published: (2018-02-01)

Osteoporosis Treatments Affect Bone Matrix Maturation in a Rat Model of Induced Cortical Remodeling
by: Ryan D Ross, et al.
Published: (2020-04-01)

Osteocyte Dysfunction in Joint Homeostasis and Osteoarthritis
by: Lanlan Zhang, et al.
Published: (2021-06-01)

Sclerostin as a novel marker of bone turnover in athletes
by: A Zagrodna, et al.
Published: (2016-02-01)

Morphological changes of alveolar bone due to orthodontic movement of maxillary and mandibulary incisors
by: Pinandi Sri Pudyani, et al.
Published: (2008-03-01)

Lipid Nanoparticle Delivery of siRNA to Osteocytes Leads to Effective Silencing of SOST and Inhibition of Sclerostin In Vivo
by: Genc Basha, et al.
Published: (2016-01-01)

Displacement in root apex and changes in incisor inclination affect alveolar bone remodeling in adult bimaxillary protrusion patients: a retrospective study
by: Huimin Mao, et al.
Published: (2020-11-01)

Decreased Sclerostin Secretion in Humans and Mice With Nonalcoholic Fatty Liver Disease
by: Fangli Zhou, et al.
Published: (2021-08-01)

Serum sclerostin is negatively associated with insulin sensitivity in obese but not lean women
by: Anouar Aznou, et al.
Published: (2021-03-01)

The Osteocyte as the New Discovery of Therapeutic Options in Rare Bone Diseases
by: Janak L. Pathak, et al.
Published: (2020-07-01)

Disparate bone anabolic cues activate bone formation by regulating the rapid lysosomal degradation of sclerostin protein
by: Nicole R Gould, et al.
Published: (2021-03-01)

Sclerostin Antibody Mitigates Estrogen Deficiency-Inducted Marrow Lipid Accumulation Assessed by Proton MR Spectroscopy
by: Shaojun Li, et al.
Published: (2019-03-01)

Bone Matrix Levels of Dickkopf and Sclerostin are Positively Correlated with Bone Mass and Strength in Postmenopausal Osteoporosis
by: Thor Ueland, et al.
Published: (2019-06-01)

Type 2 diabetes raises serum sclerostin levels and disturbs the relation between sclerostin and bone mineral density: a call for caution with antisclerostin therapy in osteoporosis
by: Dina S Al-Zifzaf, et al.
Published: (2014-01-01)

Sclerostin - a potential new marker of exercise influence on vascular calcification and mineral and bone disorder in hemodialysed adults
by: Agnieszka Turon-Skrzypinska, et al.
Published: (2019-12-01)

The association of circulating sclerostin level with markers of bone metabolism in patients with thyroid dysfunction
by: Mihaljević Olgica, et al.
Published: (2020-01-01)

Prevalence of low bone mineral density in ankylosing spondylitis, correlation with disease activity, and serum sclerostin levels
by: Anupam Wakhlu, et al.
Published: (2020-01-01)

Novel Aptamer-Based Small-Molecule Drug Screening Assay to Identify Potential Sclerostin Inhibitors against Osteoporosis
by: Chien-Ching Lee, et al.
Published: (2021-08-01)

Impact of Mechanically-Induced Microdamage and Gap Junctional Intercellular Communication on MLO-Y4 Viability and Sclerostin Expression
by: York, Spencer
Published: (2014)

Bone losses in obese, ovariectomized rats appear to be independent from sclerostin-induced inhibition of the Wnt/β-catenin pathway
by: Radosław Piotr Radzki, et al.
Published: (2020-09-01)

Skeletal Fragility in Type 2 Diabetes Mellitus
by: Jakob Starup-Linde, et al.
Published: (2018-09-01)

Bone Sclerostin and Dickkopf-related protein-1 are positively correlated with bone mineral density, bone microarchitecture, and bone strength in postmenopausal osteoporosis
by: Jia Peng, et al.
Published: (2021-05-01)

Sclerostin-Mediated Impaired Osteogenesis by Fibroblast-Like Synoviocytes in the Particle-Induced Osteolysis Model
by: Supriya Jagga, et al.
Published: (2021-06-01)

Short‐Term Glucocorticoid Treatment Reduces Circulating Sclerostin Concentrations in Healthy Young Men: A Randomized, Placebo‐Controlled, Double‐Blind Study
by: Merel Jacobsson, et al.
Published: (2020-08-01)

Sclerostin─A Debutant on the Autosomal Dominant Polycystic Kidney Disease Scene?
by: Magdalena Jankowska, et al.
Published: (2017-05-01)